Pear Therapeutics

Ronan O’Brien

Ronan O’Brien joined Pear in 2018 as Vice President, General Counsel & Secretary. Prior to Pear, Mr. O’Brien was at Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical stage biotech, where he served as Vice President & Associate General Counsel. Before Selecta, Mr. O’Brien was at Cerulean Pharma, Inc. (NASDAQ: CERU), a clinical stage biotech, where he served as Executive Director & Associate General Counsel.

Previously, Mr. O’Brien was a corporate partner at Greenberg Traurig LLP and Seyfarth Shaw LLP.

Mr. O’Brien is a graduate of Boston University’s six-year BA/JD program.

Back